← Leaderboards
Guillermo N Armaiz-Pena
University Of Tx Md Anderson Can Ctr
$3,912,936
Attributed
$6,560,175
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.6M · FY2006–25$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,361,872 · 8
By mechanism
U54$4,629,262 · 4
U01$3,760,586 · 1
R01$1,341,086 · 1
R21$523,405 · 1
F31$107,533 · 1
Top collaborators
- Alvaro N Monteiro4 shared
- Harold I Saavedra4 shared
- Eida Maria Castro3 shared
- Shelley S Tworoger2 shared
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Grace Smith$852,927
- Ronald Anthony Depinho$97,148,322
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsCancer PatientStressBiologicalChronic StressUniversitiesTumorHealth SciencesMalignant Neoplasm Of OvaryResourcesCancer CenterTumor ProgressionInnovationPsychosocialResponseAffectGrowthHormonesFutureLeadDistressSympathetic Nervous SystemPathway InteractionsPrevent
Grant awards (20)
Mental Health CPR: Transforming Cancer Survivors' Mental Health with Community Participatory Reach$1,377,752
U01 · FY2025 · CA
(1/2) Ponce Health Sciences University-Moffitt Cancer Center Partnership #$1,301,440
U54 · FY2025 · CA
The role of biobehavioral factors and anti-inflammatory medications on the ovarian tumor immune response$650,127
R01 · FY2025 · CA
PILOT PROJECT 2: Understanding the biology of an ADCK4-NUMBL fusion in lung adenocarcinoma aggressiveness$144,604
U54 · FY2025 · CA
The impact of biobehavioral factors and aspirin on ovarian cancer biology$144,604
U54 · FY2025 · CA · contact PI
Mental Health CPR: Transforming Cancer Survivors' Mental Health with Community Participatory Reach for Equity$1,376,566
U01 · FY2024 · CA
(1/2) Ponce Health Sciences University-Moffitt Cancer Center Partnership #$1,198,817
U54 · FY2024 · CA
The impact of biobehavioral factors and aspirin on ovarian cancer biology$161,838
U54 · FY2024 · CA · contact PI
(1/2) Ponce Health Sciences University-Moffitt Cancer Center Partnership #$1,301,440
U54 · FY2023 · CA
Mental Health CPR: Transforming Cancer Survivors' Mental Health with Community Participatory Reach for Equity$1,006,268
U01 · FY2023 · CA
The role of biobehavioral factors and anti-inflammatory medications on the ovarian tumor immune response$690,959
R01 · FY2023 · CA
The impact of biobehavioral factors and aspirin on ovarian cancer biology$144,604
U54 · FY2023 · CA · contact PI
Adrenergic signaling inhibition to enhance the immunogenicity of the ovarian tumor microenvironment prior to PD-1 checkpoint therapy$85,329
R21 · FY2021 · CA · contact PI
Adrenergic signaling inhibition to enhance the immunogenicity of the ovarian tumor microenvironment prior to PD-1 checkpoint therapy$438,076
R21 · FY2020 · CA · contact PI
Adrenergic modulation of ovarian cancer progression and chemoresistance$75,743
U54 · FY2019 · CA · contact PI
Adrenergic modulation of ovarian cancer progression and chemoresistance$78,086
U54 · FY2018 · CA · contact PI
Adrenergic modulation of ovarian cancer progression and chemoresistance$78,086
U54 · FY2017 · CA · contact PI
Role of Src in Stress-Mediated Progression of Ovarian Cancer$27,032
F31 · FY2009 · CA · contact PI
Role of Src in Stress-Mediated Progression of Ovarian Cancer$38,115
F31 · FY2008 · CA · contact PI
Role of Src in Stress-Mediated Progression of Ovarian Cancer$42,386
F31 · FY2006 · CA · contact PI